Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 4Phase 3 1Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 26Melanoma 24Carcinoma, Renal Cell 16Stomach Neoplasms 9Lung Neoplasms 9Squamous Cell Carcinoma of Head and Neck 6Carcinoma, Hepatocellular 6Kidney Neoplasms 5Brain Neoplasms 5Urinary Bladder Neoplasms 4Neoplasms 4Mesothelioma 4Adenocarcinoma Of Esophagus 4Skin Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Anus Neoplasms 3Various Advanced Cancer 2Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Mesothelioma, Malignant 2Liver Neoplasms 2Hodgkin Disease 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma 2Anal Canal Carcinoma 2Adenocarcinoma 2von Hippel-Lindau Disease 1

Interventions

cabozantinib 2pembrolizumab 1lenvatinib 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hyaluronoglucosaminidase 1CTLA-4 Antigen 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Clear-cell metastatic renal cell carcinoma × Nivolumab × Clear all
NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡